[Skip to Navigation]
Sign In
May 11, 2022

Error in Author Surname

JAMA Dermatol. 2022;158(6):706. doi:10.1001/jamadermatol.2022.1933

In the Letter titled “Treatment With Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma,”1 the second author’s surname was spelled “Duvicy” but should be “Duvic.” This article was corrected online on May 11, 2022.

Joshi  TP, Duvic  M, Torres-Cabala  CA, Tschen  JA.  Treatment with dupilumab for refractory cutaneous B-cell pseudolymphoma.   JAMA Dermatol. Published online April 13, 2022. doi:10.1001/jamadermatol.2022.0613Google ScholarCrossref